Diagnostic Value of Preoperative uPAR-PET/CT in Regional Lymph Node Staging of Oral and Oropharyngeal Squamous Cell Carcinoma: A Prospective Phase II Trial

Diagnostic Value of Preoperative uPAR-PET/CT in Regional Lymph Node Staging of Oral and Oropharyngeal Squamous Cell Carcinoma: A Prospective Phase II Trial

The detection of lymph node metastases is a major challenge in oral and oropharyngeal squamous cell carcinoma (OSCC and OPSCC). <sup>68</sup>Ga-NOTA-AE105 is a novel positron emission tomography (PET) radioligand with high affinity to urokinase-type plasminogen activator receptor (uPAR),...

Full description

Bibliographic Details
Main Authors:	Mads Lawaetz, Anders Christensen, Karina Juhl, Giedrius Lelkaitis, Kirstine Karnov, Esben Andreas Carlsen, Birgitte W. Charabi, Annika Loft, Dorota Czyzewska, Christian von Buchwald, Andreas Kjaer
Format:	Article
Language:	English
Published:	MDPI AG 2023-10-01
Series:	Diagnostics
Subjects:	urokinase-type plasminogen activator receptor (uPAR) PET/CT <sup>68</sup>Ga-NOTA-AE105 lymph node metastases head and neck cancer
Online Access:	https://www.mdpi.com/2075-4418/13/21/3303

Similar Items

Potential of uPAR, αvβ6 Integrin, and Tissue Factor as Targets for Molecular Imaging of Oral Squamous Cell Carcinoma: Evaluation of Nine Targets in Primary Tumors and Metastases by Immunohistochemistry
by: Mads Lawaetz, et al.
Published: (2023-02-01)

UPAR Overexpression Could Be a Potential Favorable Prognostic Marker in Invasive Ductal Carcinoma of Breast
by: Ata Abbasi, et al.
Published: (2022-06-01)

uPAR PET/CT for Prognostication and Response Assessment in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing Radium-223 Therapy: A Prospective Phase II Study
by: Marie Øbro Fosbøl, et al.
Published: (2021-06-01)

Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor – β1 (TGF-β1) and potential effects on migration and invasion
by: Synnove Norvoll Magnussen, et al.
Published: (2017-05-01)

The Urokinase Receptor (uPAR) as a “Trojan Horse” in Targeted Cancer Therapy: Challenges and Opportunities
by: Virginia Metrangolo, et al.
Published: (2021-10-01)

Identification of uPAR Variants Acting as ceRNAs in Leukaemia Cells
by: Mariaevelina Alfieri, et al.
Published: (2022-04-01)

Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR): tumor expression patterns and prognostic value in oral cancer
by: Anders Christensen, et al.
Published: (2017-08-01)

Preliminary assessment of the possibility of using urokinase uPA and urokinase receptor uPAR as universal diagnostic criteria in patients with colorectal and gastric adenocarcinoma
by: Polina S. Klimovich, et al.
Published: (2021-12-01)

New Pieces in the Puzzle of uPAR Role in Cell Migration Mechanisms
by: Anna Gorrasi, et al.
Published: (2020-11-01)

Urokinase System in Pathogenesis of Pulmonary Fibrosis: A Hidden Threat of COVID-19
by: Anna A. Shmakova, et al.
Published: (2023-01-01)

Bispecific Targeting of EGFR and Urokinase Receptor (uPAR) Using Ligand-Targeted Toxins in Solid Tumors
by: Felix Oh, et al.
Published: (2020-06-01)

Urokinase Receptor uPAR Downregulation in Neuroblastoma Leads to Dormancy, Chemoresistance and Metastasis
by: Anna A. Shmakova, et al.
Published: (2022-02-01)

The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets
by: Ashna A. Kumar, et al.
Published: (2022-01-01)

(-)-Epigallocatechin-3-Gallate Prevents IL-1β-Induced uPAR Expression and Invasiveness via the Suppression of NF-κB and AP-1 in Human Bladder Cancer Cells
by: Dhiraj Kumar Sah, et al.
Published: (2022-11-01)

The Urokinase Receptor: A Multifunctional Receptor in Cancer Cell Biology. Therapeutic Implications
by: Anna Li Santi, et al.
Published: (2021-04-01)

Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer
by: Bing-Tao Zhai, et al.
Published: (2022-03-01)

Experimental and Clinical Evidence Supports the Use of Urokinase Plasminogen Activation System Components as Clinically Relevant Biomarkers in Gastroesophageal Adenocarcinoma
by: Gary Tincknell, et al.
Published: (2021-08-01)

High-throughput optofluidic screening of single B cells identifies novel cross-reactive antibodies as inhibitors of uPAR with antibody-dependent effector functions
by: André Luiz Lourenço, et al.
Published: (2023-12-01)

Urokinase versus Alteplase in Patients with Intermediate–High-Risk Pulmonary Embolism Treated with Ultrasound-Accelerated Endovascular Thrombolysis
by: Hani Al-Terki, et al.
Published: (2023-06-01)

The Association between Plasma Levels of Intact and Cleaved uPAR Levels and the Risk of Biochemical Recurrence after Radical Prostatectomy for Prostate Cancer
by: Hein Vincent Stroomberg, et al.
Published: (2020-10-01)

Exogenous Urokinase Inhibits Proteasomal Degradation of Its Cognate Urokinase Plasminogen Activator Receptor
by: Ran Zhu, et al.
Published: (2022-08-01)

Cancer Progression Gene Expression Profiling Identifies the Urokinase Plasminogen Activator Receptor as a Biomarker of Metastasis in Cutaneous Squamous Cell Carcinoma
by: Elahe Minaei, et al.
Published: (2022-04-01)

suPAR as a marker of infection in acute kidney injury – a prospective observational study
by: Anna Hall, et al.
Published: (2018-08-01)

Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications
by: Niaz Mahmood, et al.
Published: (2018-02-01)

The uPA/uPAR system in astrocytic wound healing
by: Manuel Yepes
Published: (2022-01-01)

Identification of a Novel Small RNA Encoded in the Mouse Urokinase Receptor uPAR Gene (Plaur) and Its Molecular Target Mef2d
by: Karina D. Rysenkova, et al.
Published: (2022-07-01)

A study of the interaction between Helicobacter pylori and components of the human fibrinolytic system
by: A. Yarzábal, et al.
Published: (2000-09-01)

Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High‐Sensitivity C‐Reactive Protein
by: Salim S. Hayek, et al.
Published: (2018-05-01)

<sup>68</sup>Ga-Labeling: Laying the Foundation for an Anti-Radiolytic Formulation for NOTA-sdAb PET Tracers
by: Henri Baudhuin, et al.
Published: (2021-05-01)

Circulating Forms of Urokinase-Type Plasminogen Activator Receptor in Plasma Can Predict Recurrence and Survival in Patients with Urothelial Carcinoma of the Bladder
by: Line H. Dohn, et al.
Published: (2021-05-01)

Urokinase-type plasminogen activator is a modulator of synaptic plasticity in the central nervous system: implications for neurorepair in the ischemic brain
by: Manuel Yepes
Published: (2020-01-01)

Role of Plasminogen Activation System in Platelet Pathophysiology: Emerging Concepts for Translational Applications
by: Filomena Napolitano, et al.
Published: (2022-05-01)

Value of soluble Urokinase plasminogen activator receptor over age as a biomarker of impaired myocardial relaxation
by: Koh, Angela S., et al.
Published: (2018)

Activación y determinación de parámetros cinéticos de la Plasmina Humana y Ovis aries
by: Omaira Cañas, et al.
Published: (2011-01-01)

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin′s Lymphoma
by: Shirin Kouhpayeh, et al.
Published: (2017-01-01)

The Multifaceted Role of Plasminogen in Cancer
by: Beate Heissig, et al.
Published: (2021-02-01)

Research Progress of Targeting uPA-uPAR System in Tumor Therapy
by: CAI Weiwen, et al.
Published: (2023-02-01)

CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines
by: Alessio Biagioni, et al.
Published: (2021-05-01)

Fibrinolysis protease receptors promote activation of astrocytes to express pro-inflammatory cytokines
by: Paola Pontecorvi, et al.
Published: (2019-12-01)

The Contribution of the Urokinase Plasminogen Activator and the Urokinase Receptor to Pleural and Parenchymal Lung Injury and Repair: A Narrative Review
by: Torry A. Tucker, et al.
Published: (2021-02-01)